Retacrit (Epoetin Alfa-Epbx) Drug Interactions: 308 Moderate
Retacrit (Epoetin Alfa-Epbx) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Retacrit. Always confirm against the full prescribing information.
100 interactions
Abemaciclib
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Abemaciclib.
Level 2 evidence
Abiraterone
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Abiraterone.
Level 2 evidence
Adagrasib
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Adagrasib.
Level 2 evidence
Afatinib
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Afatinib.
Level 2 evidence
Aldesleukin
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aldesleukin.
Level 2 evidence
Alectinib
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alectinib.
Level 2 evidence
Alemtuzumab
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alemtuzumab.
Level 2 evidence
Alitretinoin
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alitretinoin.
Level 2 evidence
Alpelisib
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alpelisib.
Level 2 evidence
Aminolevulinic acid
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aminolevulinic acid.
Level 2 evidence
Anagrelide
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Anagrelide.
Level 2 evidence
Anastrozole
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Anastrozole.
Retacrit (Epoetin Alfa-Epbx) has 309 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Retacrit (Epoetin Alfa-Epbx) has 0 major, 308 moderate, and 1 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Retacrit. Always confirm against the full prescribing information.